Radiolabeled autologous INTERCEPT treated platelet components
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radiolabeled autologous INTERCEPT treated platelet components, covering 2017-11-08 to 2017-11-08. Get the full timeline:
Most recent: Clinical Trial Update: A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma [Phase 2]